This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,008,313 to The Regents of the University of California, San Francisco (UCSF) for a 3-year period from Sep 1, 2024 to Aug 31, 2027. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. UCSF, a prominent academic medical center and research institution,...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The Regents of the University of California, San Francisco will receive $565,250 from the Department of the Army Medical Command through May 2025 under a Project Grant award from the Military Medical Research and Development program (CFDA 12.420). The grant will fund research investigating mutation burden in normal skin as a predictor of melanoma risk. Specifically, the University of California, San Francisco will conduct basic, applied, and advanced biomedical research to transform military and...
This $805,901 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding the University of California, San Francisco (UCSF) to investigate the molecular basis of cutaneous melanomas in non-Caucasian patients. The 3-year research project aims to advance scientific understanding of melanoma pathogenesis in diverse patient populations and explore new potential therapeutic approaches. As a leading academic medical center,...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
This $993,283 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research at the University of California, San Francisco (UCSF) focused on proteomic determinants and components of progression in multiple sclerosis. The research seeks to transform healthcare for military service members and the general public through innovative investigations into disease prevention, diagnosis,...
This $300,000 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The award is intended to support research focused on "Identifying Regulators of Extrafollicular Plasma Cell Differentiation" over the July 2024 to July 2026 performance period. As a leading academic medical center, UCSF will leverage its expertise in biomedical research...
The Regents of the University of California, San Francisco will receive $564,954 under a three-year Project Grant from the Department of the Army Medical Command to identify novel therapeutic strategies for metastatic uveal melanoma through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and...